Osamu Takeyama
Kyoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Osamu Takeyama.
Transplantation | 1999
Takehiko Uesugi; Iwao Ikai; Toshikazu Yagi; Seiji Satoh; Akiyoshi Kanazawa; Tetsuji Yoneyama; Osamu Takeyama; Ryuta Nishitai; Nagato Katura; Hiroshi Okabe; Hiroaki Terajima; Hiroo Iwata; Yoshio Yamaoka
BACKGROUND We introduced the pharmacokinetic method into the functional evaluation of xenogeneic extracorporeal liver perfusion as an artificial liver assist device, and examined the influence of xenogeneic humoral injury on the metabolic function of xenoperfused pig livers. METHODS Isolated pig livers were perfused with fresh porcine blood (group 1; n=5) or fresh human blood (group 2; n=5) for 9 hr. Clearance (CL) of ammonia and lidocaine, and galactose elimination capacity (Vmax) were determined at three points during the perfusion using a one-compartment pharmacokinetic model. RESULTS Concentrations of ammonia and lidocaine decreased exponentially and those of galactose decreased linearly after a bolus injection in both groups. A one-compartment model provided satisfactory curve fittings for these test substances. No decreases of ammonia CL, lidocaine CL, or galactose Vmax were observed until 9 hr in either group. No differences were observed between the two groups with respect to these metabolic functions. In group 1, only slight interlobular edema was observed at 9 hr. In group 2, membrane attack complex was diffusely deposited at 3 hr and severe interlobular damage was histologically observed at 9 hr, although hepatocellular damage was minimal even at 9 hr. Alpha glutathione S-transferase and mitochondrial aspartate aminotransferase were comparable between the two groups. CONCLUSIONS Pharmacokinetic analysis allowed the evaluation of ammonia CL, lidocaine CL, and galactose Vmax of the perfused pig livers. Despite xenogeneic humoral injuries, the xenoperfused livers maintained these metabolic functions at the same levels as the alloperfused livers for 9 hr.
Transplantation | 2000
Osamu Takeyama; Iwao Ikai; Masayuki Yamamoto; Akiyoshi Kanazawa; Toshikazu Yagi; Takehiko Uesugi; Ryuta Nishitai; Seiji Satoh; Hiroaki Terajima; Yoshio Yamaoka
BACKGROUND The role of Kupffer cells in a hepatic xenograft rejection is still unclear. We investigated the effect of blocking Kupffer cells on xenogeneic humoral injury using rat livers as the xenoperfusion models. METHODS Rat livers were perfused with fresh human blood after pretreatment either with normal saline (group 1; n = 8) or with gadolinium chloride (GdCl3) solution (group 2; n = 8). Tissue injury was evaluated by alanine aminotransferase release and histological examination. Tumor necrosis factor-alpha (TNF-alpha) production from rat livers was measured by enzyme-linked immunosorbent assay and also examined by immunohistochemistry. In addition, Kupffer cells were isolated after pretreatment either with normal saline or with GdCl3 solution and incubated with human serum. Localization of human C3 and IgM was examined by immunofluorescence. RESULTS Alanine aminotransferase release in group 2 was significantly higher than in group 1 (P = 0.015). Histological examination revealed more severe tissue injury in group 2. The mean TNF-alpha level was not significantly different between the two groups. In immunohistochemistry, TNF-alpha was positive primarily on vascular endothelial cells in both groups. Immunofluorescence of saline-treated Kupffer cells showed an uptake of human C3 in the cytoplasm, whereas no uptake was observed in GdCl3-treated cells. The uptake of human IgM did not differ between the two groups. CONCLUSIONS These results suggest that Kupffer cells have a protective role in preventing xenogeneic humoral injury. Their ability to absorb xenogeneic complements may contribute to this protective mechanism.
Hepatology | 2000
Hiroshi Okabe; Iwao Ikai; Koichi Matsuo; Seiji Satoh; Hirohito Momoi; Tatsuhiko Kamikawa; Nagato Katsura; Ryuta Nishitai; Osamu Takeyama; Manabu Fukumoto; Yoshio Yamaoka
Surgery | 2000
Seiji Satoh; Iwao Ikai; Goro Honda; Hiroshi Okabe; Osamu Takeyama; Yuzo Yamamoto; Naritaka Yamamoto; Yuji Iimuro; Yasuyuki Shimahara; Yoshio Yamaoka
Liver Transplantation | 2001
Ryuta Nishitai; Iwao Ikai; Hiroaki Terajima; Akiyoshi Kanazawa; Osamu Takeyama; Takehiko Uesugi; Hiroshi Okabe; Nagato Katsura; Takakazu Matsushita; Satoshi Yamanokuchi; Koichi Matsuo; Shinichi Sugimoto; Tomohiro Shiotani; Yoshio Yamaoka
Transplantation Proceedings | 1998
Toshikazu Yagi; Seiji Satoh; Akiyoshi Kanazawa; Takehiko Uesugi; Osamu Takeyama; Tetsuji Yoneyama; Ryuta Nishitai; Hiroaki Terajima; Iwao Ikai; Yasuyuki Shimahara; Yoshio Yamaoka
Liver Transplantation | 2001
Osamu Takeyama; Iwao Ikai; Toshikazu Yagi; Seiji Satoh; Akiyoshi Kanazawa; Takehiko Uesugi; Ryuta Nishitai; Hiroshi Okabe; Nagato Katsura; Hiroaki Terajima; Yoshio Yamaoka
Journal of The Mathematical Society of Japan | 1985
Osamu Takeyama
Transplantation | 2002
Osamu Takeyama; Iwao Ikai; Yoshio Yamaoka
Journal of Surgical Research | 2001
Takehiko Uesugi; Iwao Ikai; Seiji Satoh; Toshikazu Yagi; Akiyoshi Kanazawa; Osamu Takeyama; Ryuta Nishitai; Hiroshi Okabe; Nagato Katsura; Hiroaki Terajima; Rei Takahashi; Yoshio Yamaoka